Olympus launches new CKX-CCSW cell confluency checker software

Accurate cell confluency measurements are now quick to perform on cell cultures with the Olympus CKX-CCSW confluency checker software. Without having to remove cells from the vessel, the software quantifies the exact growth density to quickly help scientists decide on the next step and optimise cultivation conditions. The new software complements the Olympus CKX53 cell culture microscope and Cell Counter Model R1, which together help accelerate, standardise and accurately document every stage of the cell culture workflow, with both speed and efficiency.

Success in cell culture applications such as stem cell research and regenerative medicine rely on routinely checking the health and growth status of cultures. Previously, microscopic inspection would provide a rough visual estimate of confluency, ascertaining whether growing cells were ready to passage or assay. Lacking standardisation, this would often lead to inconsistencies or cells exceeding the recommended growth density, negatively impacting downstream experimentation. Introducing a new level of accuracy, the CKX-CCSW confluency checker software utilises an exclusive Olympus cell counting algorithm, quickly creating quantifiable cell growth data to determine when cells require passaging, experimentation or storage.

Measurement records can be saved and exported as a CSV file for further analysis or archiving, or easily paired with associated cell culture images for comprehensive recording. In addition, the intuitive interface enables users to acquire highly accurate, reproducible data with minimal training, simplifying lab processes and analysis for every member of the team.

The new software is used with a camera-equipped cell culture microscope such as the Olympus CKX53. Once cells are ready to passage or assay, they can then also be accurately counted in-solution with the Olympus Cell Counter R1, which presents a faster and more accurate alternative to the traditional haemocytometer. Head of Core Life Science at Olympus, Wolfgang Hempell commented:

The expansion of stem cell research has sparked a demand for technologies that enable both standardisation and accurate documentation, while also increasing speed and reducing workload. With Olympus’ renowned optical and digital expertise, we are ideally placed to meet these needs, driving the future of cell culture applications.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Evident Corporation. (2019, June 19). Olympus launches new CKX-CCSW cell confluency checker software. News-Medical. Retrieved on November 29, 2022 from https://www.news-medical.net/news/20160503/Olympus-launches-new-CKX-CCSW-cell-confluency-checker-software.aspx.

  • MLA

    Evident Corporation. "Olympus launches new CKX-CCSW cell confluency checker software". News-Medical. 29 November 2022. <https://www.news-medical.net/news/20160503/Olympus-launches-new-CKX-CCSW-cell-confluency-checker-software.aspx>.

  • Chicago

    Evident Corporation. "Olympus launches new CKX-CCSW cell confluency checker software". News-Medical. https://www.news-medical.net/news/20160503/Olympus-launches-new-CKX-CCSW-cell-confluency-checker-software.aspx. (accessed November 29, 2022).

  • Harvard

    Evident Corporation. 2019. Olympus launches new CKX-CCSW cell confluency checker software. News-Medical, viewed 29 November 2022, https://www.news-medical.net/news/20160503/Olympus-launches-new-CKX-CCSW-cell-confluency-checker-software.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Olympus Provi™ CM20 wins highest honor in world-renowned design competition